Deutsch English Français

Contact

EP1922334

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1922334

EP1922334 - TUMOR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 11.11.2011 Database last updated on 30.09.2024
Most recent event Tooltip	11.11.2011	No opposition filed within time limit	published on 14.12.2011 [2011/50]
Applicant(s)	For all designated states Immatics Biotechnologies GmbH Paul-Ehrlich-Strasse 15 72076 Tübingen / DE
	[2011/01]
Former [2008/21]	For all designated states Immatics Biotechnologies GmbH Paul-Ehrlich-Str. 15 72076 Tübingen / DE
Inventor(s)	01 / SINGH, Harpreet Bei den Pferdeställen 9 72072 Tübingen / DE
	02 / EMMERICH, Niels Schönbuchstrasse 34 72074 Tübingen / DE
	03 / WALTER, Steffen Blumenstrasse 1 72411 Dusslingen / DE
	04 / WEINSCHENK, Toni Im Morgenrain 15 73773 Aichwald / DE
	[2009/24]
Former [2008/30]	01 / SINGH, Harpreet Französische Allee 6 72072 Tübingen / DE
	02 / EMMERICH, Niels Schönbuchstrasse 34 72074 Tübingen / DE
	03 / WALTER, Steffen Blumenstrasse 1 72411 Dusslingen / DE
	04 / WEINSCHENK, Toni Im Morgenrain 15 73773 Aichwald / DE
Former [2008/21]	01 / SINGH, Harpreet Ferdinand-Christian-Baur-Str. 12 72076 Tübingen / DE
	02 / EMMERICH, Niels Neckarhalde 39 72070 Tübingen / DE
	03 / WALTER, Steffen Blumenstrasse 1 72411 Dusslingen / DE
	04 / WEINSCHENK, Toni Im Morgenrain 15 73773 Aichwald / DE
Representative(s)	Krauss, Jan Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE
	[N/P]
Former [2008/21]	Krauss, Jan Forrester & Boehmert Pettenkoferstrasse 20-22 80336 München / DE
Application number, filing date	06777167.5	05.09.2006
	[2008/21]
	WO2006EP08641
Priority number, date	EP20050019255	05.09.2005 Original published format: EP 05019255
	[2008/21]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2007028573
	Date:	15.03.2007
	Language:	EN
	[2007/11]
	Type:	A1 Application with search report
	No.:	EP1922334
	Date:	21.05.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.03.2007 takes the place of the publication of the European patent application.
	[2008/21]
	Type:	B1 Patent specification
	No.:	EP1922334
	Date:	05.01.2011
	Language:	EN
	[2011/01]
Search report(s)	International search report - published on:	EP	15.03.2007
Classification	IPC:	C07K14/47, C12N15/00, A61K38/00, A61K39/00, C12P21/00	[2008/21]
	CPC:	C07K14/4748 (EP,US); C07K14/47 (KR); A61K39/00 (KR); A61P35/00 (EP); A61P37/02 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/21]
Extension states	AL	20.02.2008
	BA	20.02.2008
	HR	20.02.2008
	MK	20.02.2008
	RS	20.02.2008
Title	German:	AN HUMANE LEUKOZYTENANTIGEN-(HLA-)KLASSE-I- ODER II-MOLEKÜLE BINDENDE TUMORASSOZIIERTE PEPTIDE UND DAMIT IM ZUSAMMENHANG STEHENDER IMPFSTOFF GEGEN KREBS	[2008/21]
	English:	TUMOR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR II MOLECULES AND RELATED ANTI-CANCER VACCINE	[2008/21]
	French:	PEPTIDES ASSOCIES AUX TUMEURS SE LIANT AUX MOLECULES D'ANTIGENE DE LEUCOCYTE HUMAIN (HLA) DE CLASSE I OU II ET VACCIN CONTRE LE CANCER ASSOCIE	[2008/21]
Entry into regional phase	20.02.2008	National basic fee paid
	20.02.2008	Designation fee(s) paid
	20.02.2008	Examination fee paid
Examination procedure	20.02.2008	Examination requested [2008/21]
	26.06.2008	Despatch of a communication from the examining division (Time limit: M04)
	05.11.2008	Reply to a communication from the examining division
	15.01.2009	Despatch of a communication from the examining division (Time limit: M04)
	06.05.2009	Reply to a communication from the examining division
	17.06.2009	Despatch of a communication from the examining division (Time limit: M04)
	26.10.2009	Reply to a communication from the examining division
	27.04.2010	Date of oral proceedings
	10.05.2010	Minutes of oral proceedings despatched
	15.07.2010	Communication of intention to grant the patent
	15.11.2010	Fee for grant paid
	15.11.2010	Fee for publishing/printing paid
Opposition(s)	06.10.2011	No opposition filed within time limit [2011/50]
Fees paid	Renewal fee
	14.03.2008	Renewal fee patent year 03
	11.09.2009	Renewal fee patent year 04
	14.09.2010	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[Y]WO0006723 (YEDA RES & DEV [IL], et al) [Y] 6,11,14-22,24,25,33,35,36 * page 5, line 17 - page 22, line 33 *;
		[Y]US6096313 (JAEGER ELKE [DE], et al) [Y] 21 * page 13, column 1, line 29 - line 49 *;
		[X]US2004171543 (DUBLANCHET ANNE-CLAUDE [FR], et al) [X] 1,2 * page 32; sequence 13 *;
		[XY] - HEID H W ET AL, "Adipocyte differentiation-related protein is secreted into milk as a constituent of milk lipid globule membrane", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, (19961215), vol. 320, no. PART 3, ISSN 0264-6021, pages 1025 - 1030, XP002060680 [X] 1-5 * page 1027; figure 2 * * page 1027; figure 2 * [Y] 6,14-17,19,20,26-29
		[X] - BARNETT J ET AL., "Production, purification and characterization of human matrilysin (PUMP) from recombinant chinese hamster ovary cells", PROTEIN EXPRESSION AND PURIFICATION, (1994), vol. 5, pages 27 - 36, XP002352893 [X] 1-5 * page 34; table 2 * DOI: http://dx.doi.org/10.1006/prep.1994.1004
		[X] - WELCH AR ET AL., "Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, (1995), vol. 324, no. 1, pages 59 - 64, XP002352894 [X] 7-10,12,13,23 * page 60, column 1, line 13 - line 17 * DOI: http://dx.doi.org/10.1006/abbi.1995.9929
		[Y] - BROSSART P ET AL, "Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, (19990615), vol. 93, no. 12, ISSN 0006-4971, pages 4309 - 4317, XP002147432 [Y] 18 * page 4310, column 1, line 53 - line 61 *
		[DY] - WEINSCHENK T ET AL, "Integrated functional genomics approach for the design of patient-individual antitumor vaccines", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (20021015), vol. 62, no. 20, ISSN 0008-5472, pages 5818 - 5827, XP002266492 [DY] 11,22,24,25,33,35,36 * page 5820, column 1, line 22 - column 2, line 34 *
		[DY] - SUMI TOSHIYUKI ET AL, "Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma", ONCOLOGY REPORTS, NATIONAL HELLENIC RESEARCH FOUNDATION, ATHENS, GR, (200305), vol. 10, no. 3, ISSN 1021-335X, pages 567 - 570, XP002352032 [DY] 11,22,24,25,33,35,36 * the whole document *
		[DY] - SCHMIDT SM ET AL, "Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2 binding peptide that mediates tumor cell lysis", CANCER RESEARCH, (2004), vol. 64, pages 1164 - 1170, XP002352895 [DY] 26-29 * page 1165, column 1, line 61 - page 1167, column 2, line 24 * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-03-2538
		[Y] - BROSSART P ET AL, "Virus-mediated delivery of antigenic peptides into dendritic cells as a means to induce CTL", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, (19970401), vol. 7, no. 158, ISSN 0022-1767, pages 3270 - 3276, XP002075947 [Y] 28 * page 3272, column 2, line 5 - page 3273, column 1, line 1; figure 4 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p